Adam Kallel

Adam Kallel PhD has extensive experience in computational chemistry, medicinal chemistry, cheminformatics and scientific analysis techniques. Adam's work experience spans from 1995 to 2022, beginning with a role as a Senior Research Scientist at Ligand Pharmaceuticals. Adam then moved to Chugai Biopharmaceuticals as a Staff Scientist, where they set up their cheminformatic and computational chemistry systems. In 2000, they became a Scientist at Elitra Pharmaceuticals, then moved to Vertex Pharmaceuticals in 2007 as a Research Fellow II, where they managed a Ph.D. researcher and coached a team of chemists. In 2013, they started their own consultancy, Victrix Computational and Medicinal Chemistry Consultancy, and also took on the role of Scientific Relations at Collaborative Drug Discovery, Inc. In 2014, they became Director of Computational Chemistry at Retrophin, where they performed due diligence on new drug therapy candidates from ideation to development in pre-clinical trial settings. From 2019 to 2022, they were Senior Director of Computational Chemistry at Plexium.

Adam Kallel PhD has a B.S. in Chemistry and Adam'story from California State Polytechnic University-Pomona and a Ph.D. in Chemistry from the University of California, Los Angeles. Adam also has two certifications from LinkedIn: Introduction to AWS for Non-Engineers: 1 Cloud Concepts obtained in October 2019 and Project Management Simplified obtained in September 2019.